In a collaboration with a leading global pharmaceutical company, Volv Global applied machine learning to 24 million UK primary care records, surfacing approximately 1,200 likely-undiagnosed GEP-NET patients – and finding they are 5–7 years younger than those currently diagnosed. Approximately 1,200 UK patients have records consistent with undiagnosed GEP-NETs – roughly one additional patient

ten23 health, a global contract development and manufacturing organization (CDMO) focused on sterile and biologic drug products, today announced it has successfully obtained GMP certifications for the manufacturing and testing of Advanced Therapy Medicinal Product (ATMP) in its facilities in Basel and Visp, Switzerland.

ten23 health, the human-centric and sustainable strategic CDMO partner of choice for the pharmaceutical industry and biotech start-ups today announced the release of its 2025 Fairstainability Report, underscoring the company’s commitment to transparency, accountability, and responsible innovation across the pharmaceutical services industry.

PharmaBlock has successfully overcome the challenges associated with the application of sec-butyllithium by leveraging continuous flow technology. Following multiple rounds of wet testing, the project achieved continuous and stable operation for more than ten days and successfully completed production and delivery at the hundred-kilogram scale.

Results from prespecified assessment of End of Progression in the RAPIDe-3 Phase 3 study and clinical relevance of this newly-defined endpoint detailed in an oral presentation Evidence on the cardiovascular safety profile of deucrictibant in clinical studies to date presented